been reading a long list of-risks related to gindalbie-from the nov 2012 placementthey spell out the downside clearly there-and the need for more capitol raisings for future work programscant see any quick turn round me self here--
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%